HIV-1 DNA predicts disease progression and post-treatment virological control

eLife

Volumn 3, Issue , 2014, Pages e03821-

  Williams, James P ^a   Hurst, Jacob ^a   Stöhr, Wolfgang ^a   Robinson, Nicola ^b   Brown, Helen ^a   Fisher, Martin ^b   Kinloch, Sabine ^a   Cooper, David ^a   Schechter, Mauro ^b   Tambussi, Giuseppe ^a   Fidler, Sarah ^a   Carrington, Mary ^b   Babiker, Abdel ^a   Weber, Jonathan ^a   Koelsch, Kersten K ^a   Kelleher, Anthony D ^a   Phillips, Rodney E ^b   Frater, John ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

antiretroviral therapy; cure; HIV 1; human; human biology; infectious disease; medicine; microbiology; primary infection; reservoir

Indexed keywords

BIOLOGICAL MARKER; VIRUS RNA;

BLOOD; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; METABOLISM; PROPORTIONAL HAZARDS MODEL; TIME FACTOR; TREATMENT WITHDRAWAL; VIROLOGY; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOMARKERS; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; RNA, VIRAL; TIME FACTORS; VIRAL LOAD; WITHHOLDING TREATMENT;

EID: 84925375640     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.03821     Document Type: Article

References (0)